Robert Rouse has more than 25 years of experience in the biopharmaceutical and consulting industries, with deep expertise in market access, pricing and reimbursement, payer analytics, and value strategy. He has supported the development and launch of over 50 products across small molecule, biologic, vaccine, and gene therapy platforms. Prior to joining Beghou, Robert served as Head of Market Access at CSL Behring and held leadership roles at IQVIA, Campbell Alliance, and Deloitte Consulting. He earned a master’s degree in international business and economics from Georgetown University and a bachelor’s degree in history and public policy from Cornell University.
